Literature DB >> 650207

Plasma dopamine-beta-hydroxylase and erythrocyte acetylcholinesterase in a group of patients with Parkinson disease.

H Coelho, M Azevedo, C Proença, J M e Silva, C Manso.   

Abstract

In a group of patients with Parkinson disease there was no difference in plasma DBH activity between cases treated with L-Dopa and not treated. These patients tend to have an elevated activity of erythrocyte AChE.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 650207     DOI： 10.1007/BF01675356

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  7 in total

1.  ERYTHROCYTE ACETYLCHOLINESTERASE ACTIVITY IN ABO HEMOLYTIC DISEASE OF THE NEWBORN.

Authors:  E KAPLAN; F HERZ
Journal:  Pediatrics       Date:  1964-02       Impact factor: 7.124

2.  A new and rapid colorimetric determination of acetylcholinesterase activity.

Authors:  G L ELLMAN; K D COURTNEY; V ANDRES; R M FEATHER-STONE
Journal:  Biochem Pharmacol       Date:  1961-07       Impact factor: 5.858

3.  [Dopamine beta hydroxylase. Value and limits of its study in neurology].

Authors:  M T Miras Portugal; D Aunis; P Mandel; J M Warter; G Coquillat; M Collard; F Rohmer
Journal:  Rev Neurol (Paris)       Date:  1976-06       Impact factor: 2.607

Review 4.  A review: human erythrocyte acetylcholinesterase.

Authors:  F Herz; E Kaplan
Journal:  Pediatr Res       Date:  1973-04       Impact factor: 3.756

5.  Photometric assay of dopamine- -hydroxylase activity in human blood.

Authors:  T Nagatsu; S Udenfriend
Journal:  Clin Chem       Date:  1972-09       Impact factor: 8.327

6.  Serum dopamine-beta-hydroxylase in parkinsonism.

Authors:  E S Markianos; E Rüther
Journal:  J Neural Transm       Date:  1977       Impact factor: 3.575

Review 7.  NIH conference. Dopamine- -hydroxylase. Basic and clinical studies.

Authors:  I J Kopin; S Kaufman; H Viveros; D Jacobowitz; C R Lake; M G Ziegler; W Lovenberg; F K Goodwin
Journal:  Ann Intern Med       Date:  1976-08       Impact factor: 25.391
  7 in total
  4 in total

1.  Erythrocyte acetylcholinesterase in essential hypertension.

Authors:  J Martins e Silva; M Carlota Proença; J Braz Nogueira; J Gorjão-Clara; J Nogueira da Costa; C Manso
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

2.  Studies on erythrocyte acetylcholinesterase in essential hypertension.

Authors:  U Walter
Journal:  Klin Wochenschr       Date:  1982-08-16

Review 3.  Salivary biomarkers for the diagnosis and monitoring of neurological diseases.

Authors:  Raymond Farah; Hayat Haraty; Ziad Salame; Youssef Fares; David M Ojcius; Najwane Said Sadier
Journal:  Biomed J       Date:  2018-05-10       Impact factor: 4.910

Review 4.  Human Erythrocyte Acetylcholinesterase in Health and Disease.

Authors:  Carlota Saldanha
Journal:  Molecules       Date:  2017-09-08       Impact factor: 4.411
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.